About us

The Vaccine and Gene Therapy Institute (VGTI) at Oregon Health & Science University (OHSU) has assembled a multidisciplinary team of scientists to respond to serious viral disease threats, including AIDS, chronic viral infection-associated diseases, newly emerging viral diseases and infectious diseases of the elderly. Our Programs are intended to span the continuum between basic and clinical science, in which discoveries are rapidly advanced from the level of molecular and cellular biology through animal models and ultimately into clinical testing. Learn more

Upcoming seminars

Thursday September 27th, 2018 9:30am
VGTI Seminar Room - West Campus
Topic: Latent HCMV infection of CD34+ hematopoietic progenitor cells impairs myelopoiesis and stem cell engraftment in humanized BLT mice via up-regulation of TGFβ
Speaker: Lindsey Crawford, PhD
Assistant Staff Scientist, VGTI
Oregon Health and Science University

Thursday October 11th, 2018 9:30am
VGTI Seminar Room - West Campus
Topic: RhCMV 68-1 Induced MHC-E-Restricted T-cells Violate Epitope and MHC-restriction Paradigms
Speaker: Shaheed Abdulhaqq, PhD
Post Doctoral Scholar, VGTI
Oregon Health & Science University

Thursday October 25th, 2018 9:30am
VGTI Seminar Room - West Campus
Topic: TBA
Speaker: L. Ravi Iyer, PhD
Post Doctoral Scholar, VGTI
Oregon Health & Science University